TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
TANGO THERAPEUTICS, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Remaining financing cash flows, net (calculated) → financing reconciliation: $652,040,000.00Proceeds from issuance of common stock under stock plans → financing reconciliation: $20,624,000.00financing reconciliation → Net cash from financing activities: $672,569,000.00financing reconciliation → Payment of transaction costs: $95,000.00Sales and maturities of marketable securities → investing reconciliation: $73,102,000.00Purchase of property and equipment → investing reconciliation: $20,000.00investing reconciliation → Purchases of marketable securities: $519,095,000.00Net cash used in operating activities → operating reconciliation: $38,866,000.00Stock-based compensation → operating reconciliation: $16,892,000.00Accrued expenses and other liabilities → operating reconciliation: $5,901,000.00Noncash operating lease expense → operating reconciliation: $988,000.00Depreciation → operating reconciliation: $425,000.00operating reconciliation → Net loss: $55,342,000.00operating reconciliation → Prepaid expenses and other current assets: $5,192,000.00operating reconciliation → Accretion on marketable securities: $945,000.00operating reconciliation → Operating lease liabilities: $797,000.00operating reconciliation → Accounts payable: $759,000.00operating reconciliation → Other long-term assets: $19,000.00operating reconciliation → Other, net: $18,000.00Net cash used in investing activities → investing reconciliation: $445,973,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $159,967,000.00Net cash from financing activities → Cash sources and uses: $672,569,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $347,697,000.00Cash sources and uses → Net cash used in investing activities: $445,973,000.00Cash sources and uses → Net cash used in operating activities: $38,866,000.00Net loss: -$55,342,000.00Net loss−$55.34 MDepreciation: $425,000.00Depreciation expense+$425.00 KNoncash operating lease expense: $988,000.00Operating lease amortization+$988.00 KStock-based compensation: $16,892,000.00Stock-based compensation+$16.89 MAccretion on marketable securities: -$945,000.00Marketable securities accretion−$945.00 KOther, net: -$18,000.00Other non-cash items−$18.00 KPrepaid expenses and other current assets: -$5,192,000.00Prepaid & other assets−$5.19 MOther long-term assets: -$19,000.00Other noncurrent assets−$19.00 KAccounts payable: -$759,000.00Trade payables−$759.00 KAccrued expenses and other liabilities: $5,901,000.00Accrued & other liabilities+$5.90 MOperating lease liabilities: -$797,000.00Operating lease liabilities−$797.00 KNet cash used in operating activities: -$38,866,000.00. Cash required to fund net payments.Operating cash−$38.87 Moperating reconciliation: $63,072,000.00Payment of transaction costs: -$95,000.00Stock issuance costs−$95.00 KProceeds from issuance of common stock under stock plans: $20,624,000.00Stock plan proceeds+$20.62 MRemaining financing cash flows, net (calculated): $652,040,000.00Remaining financing (calculated)+$652.04 MNet cash from financing activities: $672,569,000.00Financing cash+$672.57 Mfinancing reconciliation: $672,664,000.00Purchase of property and equipment: $20,000.00PP&E purchases+$20.00 KSales and maturities of marketable securities: $73,102,000.00Marketable securities proceeds+$73.10 MPurchases of marketable securities: -$519,095,000.00Marketable securities purchases−$519.10 MNet cash used in investing activities: -$445,973,000.00. Cash required to fund net payments.Investing cash−$445.97 Minvesting reconciliation: $519,095,000.00Cash sources and uses: $832,536,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $159,967,000.00Beginning cash$159.97 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $347,697,000.00Ending cash$347.70 MCASH RECONCILIATIONFinancingflowsInvestingflowsOperatingflowsNet loss −$55.34M + net operating adjustments $16.48M = operating cash −$38.87MFree cash flowNot availableCash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$187.73 MEnding cash − beginning cash
Chart details

TANGO THERAPEUTICS, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
159,967,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
negative 38,866,000 US dollars. Net cash used.
Net loss
negative 55,342,000 US dollars
Depreciation
425,000 US dollars
Noncash operating lease expense
988,000 US dollars
Stock-based compensation
16,892,000 US dollars
Accretion on marketable securities
negative 945,000 US dollars
Other, net
negative 18,000 US dollars
Prepaid expenses and other current assets
negative 5,192,000 US dollars
Other long-term assets
negative 19,000 US dollars
Accounts payable
negative 759,000 US dollars
Accrued expenses and other liabilities
5,901,000 US dollars
Operating lease liabilities
negative 797,000 US dollars
Investing activities
negative 445,973,000 US dollars. Net cash used.
Purchase of property and equipment
20,000 US dollars
Sales and maturities of marketable securities
73,102,000 US dollars
Purchases of marketable securities
negative 519,095,000 US dollars
Financing activities
672,569,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the financing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from at-the-market offerings, net of issuance costs), so Proceeds from issuance of common stock and pre-funded warrants cannot be separated for this quarter. It may combine inflows and outflows.
Payment of transaction costs
negative 95,000 US dollars
Proceeds from issuance of common stock under stock plans
20,624,000 US dollars
Remaining financing cash flows, net (calculated)
652,040,000 US dollars
Operating adjustment reconciliation
63,072,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing displayed reconciliation
672,664,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
investing gross reconciliation
519,095,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
347,697,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
832,536,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
187,730,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$55.34M + net operating adjustments $16.48M = operating cash −$38.87M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Cash-flow net income is −$55,342.00 K, derived by subtracting the earlier cumulative period; the income statement reports −$55,341.00 K for the same period. The $1.00 K difference is rounding: the filing reports each amount rounded to the nearest thousand dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
  • Cash-flow net income is −$55,342.00 K, derived by subtracting the earlier cumulative period; the income statement reports −$55,341.00 K for the same period. The $1.00 K difference is rounding: the filing reports each amount rounded to the nearest thousand dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!